Arvind Mani

A pharmaceutical consultant dedicated to exploring and understanding the rapidly evolving pharmaceutical market access landscape.

[MORSE Consulting Inc @MorseConsult]

We are excited to announce that we are looking for a Backend Developer to join our team at MORSE Consulting Inc!

https://t.co/gnbkHaLP1E

#JoinOurTeam #devlife #backend #coding #backenddeveloper #fullstackdeveloper #python #healthcareInnovation

[Arvind Mani @RxPolicy]

@DougPMPRB Wish you all the best, Doug.

[MORSE Consulting Inc @MorseConsult]

Our October 2021 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT) report has 100 slides with newly updated provincial listing data up to June 30, 2021.

Learn more: https://t.co/vryffJeqzK

#HTA #CADTH #CDR #pCODR #pCPA #pCPAO #TTL #oncology #biosimilars

[MORSE Consulting Inc @MorseConsult]

The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the October 2021 status of brand negotiations.

Read More: https://t.co/jxDEMUEZ6g

#marketaccess #pharmaceutics #reimbursement #reimbursementstrategy

[MORSE Consulting Inc @MorseConsult]

Wondering if new evidence for your product might support a change to a previous #HTA recommendation. MORSE's Anita Carrie can provide an objective opinion on the likelihood of success and suggest strategies to help achieve the best possible HTA outcome.
https://t.co/bY5jxfAU6R

[MORSE Consulting Inc @MorseConsult]

@MorseConsult's CRaFT sub-report found that funding volumes and timelines for non-oncology and oncology biosimilars vary significantly across jurisdictions.

Learn more: https://t.co/4Q7qXDnIqU

#CADTH #pCPA #pharmaceutical #listing #drug #reimbursement #marketaccess

[MORSE Consulting Inc @MorseConsult]

@MorseConsult has developed a new #Oncology and #Biosimilar sub-report to accompany our CRaFT report that provides insights and metrics for oral vs IV oncolytic products in Canada

Learn more: https://t.co/464iRgsgPj

#HTA #CADTH #CDR #pCODR #INESSS #pCPA #pCPAO #TTL #cancer

[MORSE Consulting Inc @MorseConsult]

@MorseConsult is excited to announce the release our Oct 2021 edition of the CRaFT report https://t.co/V49e6CNGMY and our newest add-on Sub-Report focused on oral vs. IV #oncology #drugs and #biosimilar products https://t.co/fdKlLPbdc7

#HTA #CADTH #CDR #pCODR #INESSS #pCPA #TTL

[MORSE Consulting Inc @MorseConsult]

MORSE Consulting is a proud gold sponsor of the 2021 CADTH Symposium. Please feel free to drop by our virtual booth if you get a chance. @CADTH_ACMTS #CADTHSymp #CdnHealth

[MORSE Consulting Inc @MorseConsult]

The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the September 2021 status of brand negotiations. Read More: https://t.co/ClfvZWp82K

#marketaccess #pharmaceutics #reimbursement #reimbursementstrategy

[MORSE Consulting Inc @MorseConsult]

MORSE Consulting Inc is growing, and we are currently looking for an Oncology Health Technology Assessment (HTA) Consultant to join our team! https://t.co/Rh0tj5Nnro #HTA #Oncology #Hiring #OttawaJob, #TorontoJobs

[MORSE Consulting Inc @MorseConsult]

We are currently looking for an #Oncology Health Technology Assessment (HTA) Consultant to join our team! The position requires the ability to identify opportunities and risks related to oncology #HTA files and provide strategies and solutions. https://t.co/ICeKFJBpmj #Hiring

[MORSE Consulting Inc @MorseConsult]

Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian #Pharmaceutical #Reimbursement landscape: https://t.co/FH0F5Oz4AF

#pCPA #CADTH #PMPRB #pCODR #INESSS #Regulatory

[MORSE Consulting Inc @MorseConsult]

@MorseConsult is honoured to be joining an incredible group of speakers @SherryOQuinn, @Brougham_M , @FergMills Shanta Zurock, and @james_lebrocq at this year’s @CAHR_ACRSS Market Access 101 program. https://t.co/ZodIjdKQcn
#healthcare #innovation #reimbursement #marketaccess

[MORSE Consulting Inc @MorseConsult]

See what @MorseConsult's clients are saying about the 2021 CRaFT Report - comprehensive data analytic insights to support reimbursement forecasting need .

For more information on how to purchase a report, please visit: https://t.co/xEbfvIAMPT

[CAHR: Canadian Assoc. for Healthcare Reimbursement @CAHR_ACRSS]

Market Access 101 Registration is Now Open! Click the link for more information or to register! https://t.co/s2qFSRXKXn
#CAHR #MA101 #CMAP #Certification #Education #Reimbursement #Canada

[MORSE Consulting Inc @MorseConsult]

Expecting regulatory approval and positive HTA recommendations but don’t feel adequately prepared to negotiate with the pCPA? @MorseConsult is uniquely qualified to help clients prepare and are pleased to offer our new #pCPA Negotiation Simulation service https://t.co/jgdZSW5jM4

[MORSE Consulting Inc @MorseConsult]

Today, the Ontario Ministry Of Health released an updated version of the OPDP At A Glance report containing fiscal and benefit years 2019/20 data. You can access the report here: https://t.co/DwmpJNDgKu

[MORSE Consulting Inc @MorseConsult]

The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the February 2021 status of brand negotiations. Read More: https://t.co/4uaE1pWx4H #marketaccess #pharmaceutics #reimbursement #reimbursementstrategy

[MORSE Consulting Inc @MorseConsult]

Want to strength-test your HTA submission? MORSE’s HTA expert @AnitaCarrie_PhD is well-equipped to provide strategic advice with her 10+ years of experience leading or conducting the review of over 100 HTA submissions at CADTH. https://t.co/gPWPN6ITBf #HTA #CADTH